Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: A case study in Tanzania

Vaccine

Volumn 27, Issue 51, 2009, Pages 7167-7172

  Shim, Eunha ^a   Hampson, Katie ^b   Cleaveland, Sarah ^c   Galvani, Alison P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cost effectiveness; Post exposure prophylaxis; Rabies

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BITE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; IMMUNOTHERAPY; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEWBORN; POPULATION EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RABIES; SCHOOL CHILD; SOCIETY; TANZANIA; VACCINATION; WORLD HEALTH ORGANIZATION;

ANIMALS; COST-BENEFIT ANALYSIS; HUMANS; MODELS, ECONOMIC; POST-EXPOSURE PROPHYLAXIS; QUALITY-ADJUSTED LIFE YEARS; RABIES; RABIES VACCINES; TANZANIA;

EID: 71549123366     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.027     Document Type: Article

References (26)

1. Knobel D.L., Cleaveland S., Coleman P.G., Fevre E.M., Meltzer M.I., Miranda M.E., et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83 5 (2005) 360-368
2. Dhankhar P., Vaidya S.A., Fishbien D.B., and Meltzer M.I. Cost effectiveness of rabies post exposure prophylaxis in the United States. Vaccine 26 August (33) (2008) 4251-4255
3. Manning S.E., Rupprecht C.E., Fishbein D., Hanlon C.A., Lumlertdacha B., Guerra M., et al. Human rabies prevention-United States, 2008 recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 57 May (RR-3) (2008) 1-28
4. Hampson K., Dushoff J., Cleaveland S., Haydon D.T., Kaare M., Packer C., et al. Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol 7 March (3) (2009) e53
5. Hampson K., Dobson A., Kaare M., Dushoff J., Magoto M., Sindoya E., et al. Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Dis 2 11 (2008) e339
6. Tepsumethanon V., Wilde H., and Meslin F.X. Six criteria for rabies diagnosis in living dogs. J Med Assoc Thailand 88 3 (2005) 419-422
7. Lembo T., Hampson K., Haydon D.T., Craft M., Dobson A., Dushoff J., et al. Exploring reservoir dynamics: a case study of rabies in the Serengeti ecosystem. J Appl Ecol 45 (2008) 1246-1257
8. Quiambao B.P., Dimaano E.M., Ambas C., Davis R., Banzhoff A., and Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 23 February (14) (2005) 1709-1714
9. Cleaveland S., Fevre E.M., Kaare M., and Coleman P.G. Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. Bull World Health Organ 80 4 (2002) 304-310
10. [cited 2009 June 21]; Available from: http://www.msd.or.tz/.
11. CIA. The world factbook: Tanzania (2009). https://www.cia.gov/library/publications/the-world-factbook/geos/tz.html [cited 2009 Feb 5]. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/tz.html
12. WHO. Guide for post-exposure prophylaxis (2009). http://www.who.int/rabies/human/postexp/en/index.html [cited Feb 16 2009]. Available from: http://www.who.int/rabies/human/postexp/en/index.html
13. Haddix A.C., Teutsch S.M., Shaffer P.A., and Duet D.O. Prevention effectiveness (1996), Oxford University Press, New York, NY
14. WHO. Report of the Commission on Macroeconomics and Health. Geneva; 2002.
15. Rheingans R.D., Constenla D., Antil L., Innis B.L., and Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Public 21 4 (2007) 205-216
16. Fishbein D.B. Rabies in humans. In: Baer G. (Ed). The natural history of rabies. 2nd ed. (1991), CRC Press, Boca Raton 519-549
17. Babe's V. Treatise on rabies. 2nd ed. (1912), Baillie're et Fils, Paris pp. 883-930
18. Baltazard M., and Ghodssi M. Prevention of human rabies; treatment of persons bitten by rabid wolves in Iran. Bull World Health Organ 10 5 (1954) 797-803
19. Shah U., and Jaswal G.S. Victims of a rabid wolf in India: effect of severity and location of bites on development of rabies. J Infect Dis 134 1 (1976) 25-29
20. WHO. Rabies; 2090 [cited 2009 July 12]. Available from: http://www.who.int/zoonoses/diseases/rabies/en/.
21. Gautret P., Soula G., Adamou H., Soavi M.J., Delmont J., Rotivel Y., et al. Rabies postexposure prophylaxis, Marseille, France 1994-2005. Emerg Infect Dis 14 9 (2008) 1452-1454
22. ECDC. Expert consulation on rabies post-exposure prophylaxis (2009), Stockholm 15 January
23. Kaare M., Lembo T., Hampson K., Ernest E., Estes A., Mentzel C., et al. Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination. Vaccine 27 January (1) (2009) 152-160
24. Murray C.J.L., and Lopez A.D. Global health statistics: a compendium of incidence, prevalence and mortality estimates for over 200 conditions (1996), Harvard School of Public Health, Boston, MA
25. Meltzer M.I., and Rupprecht C.E. A review of the economics of the prevention and control of rabies. Part 1. Global impact and rabies in humans. Pharmacoeconomics 14 4 (1998) 365-383
26. Hollinghurst S., Bevan G., and Bowie C. Estimating the "avoidable" burden of disease by disability adjusted life years (DALYs). Health Care Manage Sci 3 1 (2000) 9-21